US Stock MarketDetailed Quotes

PLRX Pliant Therapeutics

Watchlist
  • 14.030
  • +0.540+4.00%
Close Dec 26 16:00 ET
  • 14.030
  • 0.0000.00%
Post 16:37 ET
853.78MMarket Cap-4.19P/E (TTM)

Pliant Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
10.91%-32.27M
-82.95%-45.3M
0.02%-30.27M
-22.96%-116.36M
19.65%-25.1M
-95.83%-36.22M
-1.49%-24.76M
-47.70%-30.28M
-25.43%-94.63M
-57.26%-31.24M
Net income from continuing operations
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-26.79%-123.32M
-42.92%-35.06M
Depreciation and amortization
18.75%532K
30.40%622K
13.50%513K
0.99%1.84M
1.98%464K
-1.32%448K
3.92%477K
-0.66%452K
18.76%1.82M
8.85%455K
Other non cash items
35.51%809K
83.41%1.15M
11.82%681K
28.63%2.39M
-6.86%557K
3.65%597K
42.50%627K
149.59%609K
11.32%1.86M
653.70%598K
Change In working capital
683.74%14.25M
-127.56%-1.71M
251.31%4.73M
-70.33%1.25M
109.30%609K
-134.95%-2.44M
817.43%6.21M
-200.90%-3.13M
-39.03%4.22M
-2,107.67%-6.55M
-Change in receivables
--0
--0
--0
13,120.00%1.98M
--0
-54.95%1.58M
145.91%1.72M
-275.43%-1.31M
-99.79%15K
-29.12%-501K
-Change in prepaid assets
405.86%5.43M
-157.76%-3.44M
887.61%3.75M
-1,170.41%-3.74M
94.76%-152K
-354.15%-1.77M
-249.11%-1.33M
-146.99%-476K
87.03%-294K
-112.23%-2.9M
-Change in payables and accrued expense
557.09%8.9M
-68.48%2.05M
297.51%1.35M
-12.25%5.75M
192.81%1.87M
-165.68%-1.95M
54.93%6.51M
-148.51%-682K
82.74%6.55M
-181.75%-2.02M
-Change in other current assets
-97.28%10K
----
----
--0
-52.92%-367K
--367K
----
----
187.14%201K
-153.33%-240K
-Change in other current liabilities
87.72%-82K
58.53%-282K
44.66%-363K
-21.66%-2.75M
16.42%-743K
-7.05%-668K
-44.68%-680K
-138.55%-656K
-28.73%-2.26M
-6.34%-889K
Cash from discontinued investing activities
Operating cash flow
10.91%-32.27M
-82.95%-45.3M
0.02%-30.27M
-22.96%-116.36M
19.65%-25.1M
-95.83%-36.22M
-1.49%-24.76M
-47.70%-30.28M
-25.43%-94.63M
-57.26%-31.24M
Investing cash flow
Cash flow from continuing investing activities
-19.07%30.96M
146.57%10.7M
134.18%59.55M
15.44%-127.01M
59.43%31.92M
121.46%38.25M
-453.78%-22.98M
-11,478.71%-174.21M
-303.81%-150.2M
-22.34%20.02M
Net PPE purchase and sale
-853.19%-896K
-107.46%-1.25M
-815.34%-1.49M
47.67%-921K
63.25%-61K
86.49%-94K
-137.40%-603K
74.69%-163K
9.88%-1.76M
71.96%-166K
Net investment purchase and sale
-16.93%31.86M
153.42%11.95M
135.07%61.04M
15.06%-126.09M
58.42%31.98M
121.60%38.35M
-431.53%-22.38M
-8,102.07%-174.05M
-296.22%-148.44M
-23.46%20.19M
Cash from discontinued investing activities
Investing cash flow
-19.07%30.96M
146.57%10.7M
134.18%59.55M
15.44%-127.01M
59.43%31.92M
121.46%38.25M
-453.78%-22.98M
-11,478.71%-174.21M
-303.81%-150.2M
-22.34%20.02M
Financing cash flow
Cash flow from continuing financing activities
-22.32%543K
324.84%684K
-92.03%21.79M
20.96%274.41M
-22.89%219K
-99.68%699K
-98.46%161K
178,744.44%273.33M
8,877.21%226.85M
-44.96%284K
Net issuance payments of debt
--0
--0
--19.91M
--0
--0
--0
--0
--0
--10M
--0
Net common stock issuance
-29.84%543K
-35.84%2.56M
--0
26.52%275.25M
321.82%232K
-99.64%774K
--4M
--270.25M
7,190.92%217.56M
-89.83%55K
Proceeds from stock option exercised by employees
----
----
-48.68%1.88M
----
----
----
----
7,078.43%3.66M
----
----
Net other financing activities
----
----
----
-19.80%-847K
-105.68%-13K
89.45%-75K
-723.81%-173K
-187.25%-586K
-54.70%-707K
1,016.00%229K
Cash from discontinued financing activities
Financing cash flow
-22.32%543K
324.84%684K
-92.03%21.79M
20.96%274.41M
-22.89%219K
-99.68%699K
-98.46%161K
178,744.44%273.33M
8,877.21%226.85M
-44.96%284K
Net cash flow
Beginning cash position
48.98%81.87M
12.93%115.78M
92.12%64.72M
-34.80%33.68M
29.28%57.68M
119.19%54.95M
215.03%102.53M
-34.80%33.69M
1.54%51.67M
-1.36%44.62M
Current changes in cash
-128.23%-770K
28.72%-33.91M
-25.83%51.06M
272.58%31.03M
164.37%7.04M
-86.04%2.73M
-536.47%-47.58M
460.05%68.84M
-2,396.42%-17.98M
-269.93%-10.93M
End cash Position
40.60%81.1M
48.98%81.87M
12.93%115.78M
92.13%64.72M
92.13%64.72M
29.28%57.68M
119.19%54.95M
215.03%102.53M
-34.80%33.68M
-34.80%33.68M
Free cash flow
8.67%-33.17M
-83.53%-46.55M
-4.35%-31.76M
-21.67%-117.28M
19.88%-25.16M
-89.22%-36.32M
-2.89%-25.36M
-43.97%-30.44M
-24.54%-96.39M
-53.52%-31.41M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 10.91%-32.27M-82.95%-45.3M0.02%-30.27M-22.96%-116.36M19.65%-25.1M-95.83%-36.22M-1.49%-24.76M-47.70%-30.28M-25.43%-94.63M-57.26%-31.24M
Net income from continuing operations -39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M-26.79%-123.32M-42.92%-35.06M
Depreciation and amortization 18.75%532K30.40%622K13.50%513K0.99%1.84M1.98%464K-1.32%448K3.92%477K-0.66%452K18.76%1.82M8.85%455K
Other non cash items 35.51%809K83.41%1.15M11.82%681K28.63%2.39M-6.86%557K3.65%597K42.50%627K149.59%609K11.32%1.86M653.70%598K
Change In working capital 683.74%14.25M-127.56%-1.71M251.31%4.73M-70.33%1.25M109.30%609K-134.95%-2.44M817.43%6.21M-200.90%-3.13M-39.03%4.22M-2,107.67%-6.55M
-Change in receivables --0--0--013,120.00%1.98M--0-54.95%1.58M145.91%1.72M-275.43%-1.31M-99.79%15K-29.12%-501K
-Change in prepaid assets 405.86%5.43M-157.76%-3.44M887.61%3.75M-1,170.41%-3.74M94.76%-152K-354.15%-1.77M-249.11%-1.33M-146.99%-476K87.03%-294K-112.23%-2.9M
-Change in payables and accrued expense 557.09%8.9M-68.48%2.05M297.51%1.35M-12.25%5.75M192.81%1.87M-165.68%-1.95M54.93%6.51M-148.51%-682K82.74%6.55M-181.75%-2.02M
-Change in other current assets -97.28%10K----------0-52.92%-367K--367K--------187.14%201K-153.33%-240K
-Change in other current liabilities 87.72%-82K58.53%-282K44.66%-363K-21.66%-2.75M16.42%-743K-7.05%-668K-44.68%-680K-138.55%-656K-28.73%-2.26M-6.34%-889K
Cash from discontinued investing activities
Operating cash flow 10.91%-32.27M-82.95%-45.3M0.02%-30.27M-22.96%-116.36M19.65%-25.1M-95.83%-36.22M-1.49%-24.76M-47.70%-30.28M-25.43%-94.63M-57.26%-31.24M
Investing cash flow
Cash flow from continuing investing activities -19.07%30.96M146.57%10.7M134.18%59.55M15.44%-127.01M59.43%31.92M121.46%38.25M-453.78%-22.98M-11,478.71%-174.21M-303.81%-150.2M-22.34%20.02M
Net PPE purchase and sale -853.19%-896K-107.46%-1.25M-815.34%-1.49M47.67%-921K63.25%-61K86.49%-94K-137.40%-603K74.69%-163K9.88%-1.76M71.96%-166K
Net investment purchase and sale -16.93%31.86M153.42%11.95M135.07%61.04M15.06%-126.09M58.42%31.98M121.60%38.35M-431.53%-22.38M-8,102.07%-174.05M-296.22%-148.44M-23.46%20.19M
Cash from discontinued investing activities
Investing cash flow -19.07%30.96M146.57%10.7M134.18%59.55M15.44%-127.01M59.43%31.92M121.46%38.25M-453.78%-22.98M-11,478.71%-174.21M-303.81%-150.2M-22.34%20.02M
Financing cash flow
Cash flow from continuing financing activities -22.32%543K324.84%684K-92.03%21.79M20.96%274.41M-22.89%219K-99.68%699K-98.46%161K178,744.44%273.33M8,877.21%226.85M-44.96%284K
Net issuance payments of debt --0--0--19.91M--0--0--0--0--0--10M--0
Net common stock issuance -29.84%543K-35.84%2.56M--026.52%275.25M321.82%232K-99.64%774K--4M--270.25M7,190.92%217.56M-89.83%55K
Proceeds from stock option exercised by employees ---------48.68%1.88M----------------7,078.43%3.66M--------
Net other financing activities -------------19.80%-847K-105.68%-13K89.45%-75K-723.81%-173K-187.25%-586K-54.70%-707K1,016.00%229K
Cash from discontinued financing activities
Financing cash flow -22.32%543K324.84%684K-92.03%21.79M20.96%274.41M-22.89%219K-99.68%699K-98.46%161K178,744.44%273.33M8,877.21%226.85M-44.96%284K
Net cash flow
Beginning cash position 48.98%81.87M12.93%115.78M92.12%64.72M-34.80%33.68M29.28%57.68M119.19%54.95M215.03%102.53M-34.80%33.69M1.54%51.67M-1.36%44.62M
Current changes in cash -128.23%-770K28.72%-33.91M-25.83%51.06M272.58%31.03M164.37%7.04M-86.04%2.73M-536.47%-47.58M460.05%68.84M-2,396.42%-17.98M-269.93%-10.93M
End cash Position 40.60%81.1M48.98%81.87M12.93%115.78M92.13%64.72M92.13%64.72M29.28%57.68M119.19%54.95M215.03%102.53M-34.80%33.68M-34.80%33.68M
Free cash flow 8.67%-33.17M-83.53%-46.55M-4.35%-31.76M-21.67%-117.28M19.88%-25.16M-89.22%-36.32M-2.89%-25.36M-43.97%-30.44M-24.54%-96.39M-53.52%-31.41M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Broadcom
AVGO
+2.37%
Alibaba
BABA
+0.65%
Adobe
ADBE
+0.50%
Apple
AAPL
+0.32%
Cisco
CSCO
+0.22%

Unlock the Full List